These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12584776)

  • 61. Hepatitis B vaccination follow-up.
    McIntyre PG
    Lancet; 1995 Jun; 345(8964):1575. PubMed ID: 7791464
    [No Abstract]   [Full Text] [Related]  

  • 62. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Statement on alternate adolescent schedule for hepatitis B vaccine (ACS-5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2000 Jul; 26():19-20. PubMed ID: 10927839
    [No Abstract]   [Full Text] [Related]  

  • 66. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions.
    van den Berg R; van Hoogstraten I; van Agtmael M
    AIDS Rev; 2009; 11(3):157-64. PubMed ID: 19654857
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatitis B and the healthcare worker.
    Ala Nurse; 2007; 34(1):1, 5-6. PubMed ID: 17432324
    [No Abstract]   [Full Text] [Related]  

  • 71. Study on hepatitis B and C serologic status among municipal solid waste workers in Messina (Italy).
    Squeri R; La Fauci V; Sindoni L; Cannavò G; Ventura Spagnolo E
    J Prev Med Hyg; 2006 Sep; 47(3):110-3. PubMed ID: 17217188
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The first identified hepatitis B virus vaccine escape mutation in Turkey.
    Kutlu T; Soycan LY; Karatayli E; Türkyilmaz AR; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2006 Feb; 35(2):201-2. PubMed ID: 16230046
    [No Abstract]   [Full Text] [Related]  

  • 73. Vaccine immunogenicity in injecting drug users.
    Schmidt M
    Lancet Infect Dis; 2009 Feb; 9(2):77-8. PubMed ID: 19179222
    [No Abstract]   [Full Text] [Related]  

  • 74. [Immunogenicity and efficacy of a new recombinant DNA vaccine for hepatitis B virus in Peru].
    Lozano M A; Caycho O J; Antunez de Mayolo A; Vera D; Posadas R D
    Rev Gastroenterol Peru; 2003; 23(4):259-64. PubMed ID: 14716420
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A study on immune efficacy in children immunized by hepatitis B vaccine in disease surveillance points of Fujian].
    Li L; Zhou Y; Zhao L; Xia S; Wang Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):372-4. PubMed ID: 15617252
    [TBL] [Abstract][Full Text] [Related]  

  • 77. No seroconversion after hepatitis B immunization.
    Aggarwal A
    Indian Pediatr; 1998 Feb; 35(2):179-81. PubMed ID: 9707865
    [No Abstract]   [Full Text] [Related]  

  • 78. Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults.
    Rebedea I; Diaconescu IG; Bach D; Bartelsen O; Arndtz N
    Vaccine; 2006 Jun; 24(25):5320-6. PubMed ID: 16707195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatitis B testing and vaccination in patients recently diagnosed with HIV infection(Int J STD AIDS 2008;19:83-4).
    Brook MG; Rubinstein L; King G
    Int J STD AIDS; 2008 Jul; 19(7):501. PubMed ID: 18574131
    [No Abstract]   [Full Text] [Related]  

  • 80. Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine.
    Adwan K; Abu-Hasan N; Adwan G; Abu-Khater K
    East Mediterr Health J; 2005 May; 11(3):494-8. PubMed ID: 16602472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.